Status:
UNKNOWN
Periocular Basal Cell Carcinoma (BCC): Permanent vs. Frozen Section Pathological Control
Lead Sponsor:
Queen's University
Conditions:
Basal Cell Carcinoma
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This study is an equivalency study designed as a randomized clinical trial. Patients with a biopsy proven nodular periocular basal cell carcinoma (BCC) who have agreed to have surgical excision will b...
Detailed Description
Basal cell carcinoma (BCC) accounts for 80-90% of skin cancers and is the most common skin cancer of the periocular region. Surgical excision is considered the gold-standard in therapy. Previous liter...
Eligibility Criteria
Inclusion
- 18 years old or greater
- Diagnosed with clinically nodular BCC in the periocular region confirmed by tissue biopsy
- Agreeable and medically able to undergo surgical excision of the BCC
- Able to give informed consent and consent has been signed
- Able to return for all follow up visits
Exclusion
- BCC greater than 2cm in diameter (based on clinical examination)
- Patient with a medical condition predisposing to multiple BCC's (ex. basal cell nevus syndrome)
- Recurrent BCC's (i.e. a BCC that has been treated previously by surgical or other modality and has recurred will not be eligible)
- Clinically aggressive morpheaform subtype of BCC
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2013
Estimated Enrollment :
290 Patients enrolled
Trial Details
Trial ID
NCT00663650
Start Date
August 1 2008
End Date
June 1 2013
Last Update
July 12 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hotel Dieu Hospital
Kingston, Ontario, Canada, K7L 5G2